Pyrrolidinyl derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
US9302987B2 · kind B2 · utility
0Cited by
21References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2015 |
| Grant date | Apr 5, 2016 |
| Priority date | — |
| Expiry date | Mar 13, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.